VKTXViking Therapeutics, Inc.
33.89USD-5.81%Mkt Cap: 3.95B $P/E: —3d ago
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue an…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap3.95B $
Enterprise Value3.51B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-359.64M $
Revenue/Share—
Last Price33.89 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees65
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92686J1060
Valuation
P/E (Trailing)—
P/E (Forward)-7.95
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B9.82
EPS (TTM)-4.46
EPS (Forward)-4.32
52W Range
22.9654% of range43.15
52W High43.15 USD
52W Low22.96 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-56.28%
ROA-50.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-278.69M $
CapEx (TTM)—
FCF Margin—
FCF Yield-5.84%
Net Debt-497.58M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio4.72
Quick Ratio4.58
Book Value/Sh3.500 USD
Cash/Share4.300 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)92.39 USD
Upside (mean)+172.6%
Target Range35.00 USD – 125.00 USD
$35.00+172.6% to mean$125.00
# Analysts19
Ownership
Shares Out.116.65M
Float113.73M
Insiders3.09%
Institutions66.12%
Short Interest
Short Ratio9.8d
Short % Float20.42%
Short % Out.19.32%
Shares Short22.54M
Short (prev mo.)23.51M
Technical
SMA 5034.96 (-3.1%)
SMA 20033.73 (+0.5%)
Beta0.69
S&P 52W Chg18.16%
Avg Vol (30d)1.82M
Avg Vol (10d)1.75M
Technical Indicators
RSI (14)48.0
MACD-0.3022
MACD Signal-0.4207
MACD Hist.+0.1185
BB Upper35.76 USD
BB Middle33.78 USD
BB Lower31.81 USD
BB Width11.70%
ATR (14)1.660 USD
Vol Ratio (20d)0.77x